Search details
1.
N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation.
Mol Cancer
; 23(1): 5, 2024 01 06.
Article
in English
| MEDLINE | ID: mdl-38184597
2.
A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer.
Biochem Genet
; 62(1): 112-124, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37270714
3.
Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment.
Neoplasma
; 69(5): 1129-1137, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-36131607
4.
Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinoma.
Int J Cancer
; 144(6): 1421-1431, 2019 03 15.
Article
in English
| MEDLINE | ID: mdl-30070688
5.
MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
BMC Cancer
; 17(1): 673, 2017 Oct 04.
Article
in English
| MEDLINE | ID: mdl-28978307
6.
MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression.
Gynecol Oncol
; 143(3): 655-663, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27726922
7.
CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer.
Arch Gynecol Obstet
; 294(2): 333-42, 2016 08.
Article
in English
| MEDLINE | ID: mdl-26695643
8.
Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/ß-catenin signaling.
BMC Cancer
; 15: 107, 2015 Mar 08.
Article
in English
| MEDLINE | ID: mdl-25880337
9.
Single-Cell Atlas of Human Ovaries Reveals The Role Of The Pyroptotic Macrophage in Ovarian Aging.
Adv Sci (Weinh)
; 11(4): e2305175, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38036420
10.
FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.
Gynecol Oncol
; 127(3): 601-10, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-22943878
11.
Successful management of mucinous ovarian cancer by conservative surgery in week 6 of pregnancy: case report and literature review.
Arch Gynecol Obstet
; 286(4): 989-93, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22850888
12.
[Retracted] MicroRNA1297 inhibits metastasis and epithelialmesenchymal transition by targeting AEG1 in cervical cancer.
Oncol Rep
; 48(3)2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35856442
13.
Family with sequence similarity 46 member a confers chemo-resistance to ovarian carcinoma via TGF-ß/Smad2 signaling.
Bioengineered
; 13(4): 10629-10639, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35465837
14.
The value of first-trimester platelet parameters in predicting gestational diabetes mellitus.
J Matern Fetal Neonatal Med
; 35(11): 2031-2035, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-32594791
15.
Tumor antigen-pulsed CD8α(+) dendritic cells induce T cell-mediated graft-versus-tumor effect in vitro.
J Huazhong Univ Sci Technolog Med Sci
; 31(6): 728-734, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-22173490
16.
PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival.
Aging (Albany NY)
; 13(6): 8975-8988, 2021 03 11.
Article
in English
| MEDLINE | ID: mdl-33705352
17.
FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway.
Oncogenesis
; 10(1): 6, 2021 Jan 09.
Article
in English
| MEDLINE | ID: mdl-33423038
18.
Overexpression of glycosyltransferase 8 domain containing 2 confers ovarian cancer to CDDP resistance by activating FGFR/PI3K signalling axis.
Oncogenesis
; 10(7): 55, 2021 Jul 22.
Article
in English
| MEDLINE | ID: mdl-34294681
19.
PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer.
Mol Ther Oncolytics
; 20: 499-507, 2021 Mar 26.
Article
in English
| MEDLINE | ID: mdl-33738336
20.
Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials.
Biosci Rep
; 40(3)2020 03 27.
Article
in English
| MEDLINE | ID: mdl-32096544